SCHEMBL360969

SCHEMBL360969

CCCCOC(=O)N1CCC(OC(C)=O)c2nc(-c3ccc(C)cc3)c(-c3ccc(C)cc3)nc21

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ POLB P06746 2/20 0.36
▸ ADRB2 P07550 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ KDM1A O60341 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ AGTR2 P50052 2/20 0.33
▸ SMYD3 Q9H7B4 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ ATM Q13315 1/20 0.32
▸ MIF P14174 1/20 0.32
▸ HRH2 P25021 1/20 0.32
▸ HRH1 P35367 1/20 0.32
▸ FKBP1A P62942 1/20 0.32
▸ HTR1B P28222 1/20 0.32
▸ HTR2B P41595 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL360830 0.86 MEN1 (0.37) MEN1KMT2APOLBADRB2ALDH1A1
SCHEMBL15111310 0.83 GPR119 (0.39) KMT2AKDM1ALMNA
SCHEMBL362106 0.80 POLB (0.35) MEN1KMT2APOLBADRB2ALDH1A1
SCHEMBL361473 0.74 CKS1B (0.38) ALDH1A1
SCHEMBL362762 0.74 LTB4R (0.36) ALDH1A1KDM1AATM
SCHEMBL360863 0.71 CKS1B (0.43) KDM1A
SCHEMBL15110449 0.69 GPR119 (0.41) KMT2AKDM1ALMNA
SCHEMBL360892 0.69 KDM1A (0.36) MEN1KMT2AALDH1A1KDM1AHRH2
SCHEMBL362961 0.68 GPR119 (0.41) KMT2AKDM1ALMNA
SCHEMBL15110882 0.67 KDM1A (0.38) MEN1KMT2AALDH1A1KDM1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593452-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS Novartis AG (CH) 2013-05-22 — — EP disclosed
WO-2012007539-A9 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS NOVARTIS AG (CH) 2012-11-01 — — WO disclosed
WO-2012007539-A1 IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS NOVARTIS AG (CH) 2012-01-19 — — WO disclosed
Send feedback